Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Anxiolysis for Emergency Department Procedures in Pediatric Patients Using Intranasal Ketamine Compared With Intranasal Midazolam: A Randomized Controlled Trial

To see complete record on, please visit this link

Id: NCT03043430

Organisation Name: Brooke Army Medical Center

Overal Status: Suspended

Start Date: May 2016

Last Update: July 21, 2021

Lead Sponsor: Brooke Army Medical Center

Brief Summary: Investigators plan to conduct a randomized, double-blinded, controlled study among pediatric patients requiring minor procedures in the Emergency Department setting. Patients will be randomized to one of two arms of intranasal treatments: ketamine 1.0 mg/kg (K) or midazolam 0.3 mg/kg (M). The primary outcome will be change in anxiety using the Modified Yale Preoperative Anxiety Scale (mYPAS).

  • Anxiety
  • Pediatric ALL
  • Procedural Anxiety

Total execution time in seconds: 0.20665884017944